Tirzepatide
Tirzepatide is a pharmaceutical drug with 193 clinical trials. Currently 86 active trials ongoing. Historical success rate of 98.6%.
Success Metrics
Based on 70 completed trials
Phase Distribution
Phase Distribution
33
Early Stage
58
Mid Stage
76
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.6%
70 of 74 finished
5.4%
4 ended early
86
trials recruiting
193
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide for Treatment of CCCA
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
Clinical Trials (193)
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide for Treatment of CCCA
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
Tirzepatide in Idiopathic Intracranial Hypertension Trial
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
GLP-1R Actions on Muscle and the Skeleton
A Study to Evaluate ALN-2232 in Participants With Obesity
Tirzepatide in MetALD
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer Survivors
Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese Patients
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 193